Managing Side Effects Based on Dosing Time Gastrointestinal side effects particularly nausea, vomiting, diarrhoea, and constipationare the most commonly reported adverse effects of GLP-1 medications, especially during the initial weeks of treatment or following dose escalation
Asia Pacific is expected to witness rapid growth due to expanding healthcare access and increasing awareness regarding metabolic disease management
As the Food and Drug Administration cracks down on compounded versions of popular weight loss drugs Wegovy (semaglutide) and Zepbound (tirzepatide), Americans who rely on these cheaper medications may be drawn to a dicey sector of the dietary supplement market
Patients who already have reflux, constipation, irritable bowel symptoms, gallbladder history, diabetes medications, kidney concerns, low blood pressure, limited appetite, or difficulty maintaining protein intake should be especially proactive
One of the most common is nausea
Trends & Industry Outlook FDA Outlines Priorities for the Future of Drug Development The FDA's latest budget justification highlights continued investment in regulatory science, data modernization, AI readiness, and accelerating innovation across the product lifecycle